Characteristics of changes in HBsAg, HBV DNA and ALT after cessation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 9, Pages: 1076-1082(2025)
Clinical Research|更新时间:2025-10-10
分享给微信好友或者朋友圈
导出参考文献
Characteristics of changes in HBsAg, HBV DNA and ALT after cessation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
“The latest research has found that patients with negative hepatitis B virus surface antigen have a lower risk of virological recurrence and liver dysfunction after discontinuing nucleoside analogue therapy.”
作者机构:
1.中国科学技术大学附属第一医院,安徽合肥 230001
2.解放军总医院第五医学中心感染病医学部/国家感染性疾病临床医学研究中心,北京 100039
3.解放军总医院第五医学中心老年医学科,北京 100039
作者简介:
Wang Fu-Sheng, E-mail: fswang302@163.com
Chen Yong-Qian, E-mail: chengyq302@126.com
基金信息:
the National Key Research and Development Program of China(2023YFC2308104;2019YFC0840704);the National Natural Science Foundation of China(82130019)
Lyu Qiao-Lan,Liu Li,Qing Song,et al.Characteristics of changes in HBsAg, HBV DNA and ALT after cessation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B[J].Medical Journal of Chinese People′s Liberation Army,2025,50(09):1076-1082.
Lyu Qiao-Lan,Liu Li,Qing Song,et al.Characteristics of changes in HBsAg, HBV DNA and ALT after cessation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B[J].Medical Journal of Chinese People′s Liberation Army,2025,50(09):1076-1082. DOI: 10.11855/j.issn.0577-7402.0641.2025.0613.
Characteristics of changes in HBsAg, HBV DNA and ALT after cessation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B